Loading organizations...
§ Private Profile · Mölndal, Vastra Gotaland, Sweden
Biotechnology company developing RNA-based therapeutics.
Ribocure Pharmaceuticals has raised $120.0M across 1 funding round.
Ribocure Pharmaceuticals has raised $120.0M in total across 1 funding round.
Ribocure Pharmaceuticals has raised $120.0M in total across 1 funding round.
Ribocure Pharmaceuticals's investors include CDH Investments, China Renaissance.
Ribocure Pharmaceuticals has raised $120.0M across 1 funding round. Most recently, it raised $120.0M Series B in March 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 28, 2022 | $120M Series B | CDH Investments, China Renaissance | — | Announced |